# ANJESO
> **NDA210583** · New Drug Application · Sponsor: BAUDAX · Approved 2020-02-20
## Drug
- **FDA Application Number:** NDA210583
- **Application type:** New Drug Application
- **Brand name:** ANJESO
- **Generic name:** Meloxicam
- **Active ingredients:** MELOXICAM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAUDAX
- **First approval:** 2020-02-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210583)
---
*MORVS · CC0 1.0*